Proposed Collection; Comment Request; Brain Power! The NIDA Junior Scientist Program and the Companion Program, Brain Power! Challenge, 36659-36660 [2010-15608]
Download as PDF
36659
Federal Register / Vol. 75, No. 123 / Monday, June 28, 2010 / Notices
ANNUAL BURDEN ESTIMATES
National Medical Support Notice .....................................................................
Estimated Total Annual Burden
Hours: 897,574.50.
In compliance with the requirements
of Section 506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Dated: June 23, 2010.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2010–15636 Filed 6–25–10; 8:45 am]
BILLING CODE 4184–01–P
54
97,775
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment
Request; Brain Power! The NIDA
Junior Scientist Program and the
Companion Program, Brain Power!
Challenge
SUMMARY: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for the opportunity for public comment
on proposed data collection projects, the
National Institute on Drug Abuse
(NIDA), the National Institutes of Health
(NIH) will publish periodic summaries
of proposed projects to be submitted to
the Office of Management and Budget
(OMB) for review and approval.
Proposed Collection: Title: Brain
Power! The NIDA Junior Scientist
Program, for grades K–5, and the
companion program for Middle School,
the Brain Power! Challenge.
Type of Information Collection
Request: NEW.
Need and Use of Information
Collection: This is a request for
clearance to evaluate the effectiveness of
the Brain Power! Program’s ability to:
• Increase students’ knowledge about
the biology of the brain and the
neurobiology of drug addiction;
• Increase positive attitudes toward
science, careers in science, and science
as an enjoyable endeavor, and
stimulating interest in scientific careers;
and
• Promote more balanced perceptions
and attitudes of scientists as being of
many races, ages, and genders
The secondary goal is to determine the
influence or change of attitudes toward
Number of
respondents
Types of respondents
jlentini on DSKJ8SOYB1PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Instrument
Average
burden hours
per response
0.17
Total burden
hours
897,574.50
and intentions about drug use. The
findings will provide valuable
information concerning the goals of
NIDA’s Science Education Program of
increasing scientific literacy and
stimulating interest in scientific careers.
In order to test the effectiveness of the
evaluation, information will be
collected from students before and after
exposure to the curriculum with preand post-test self-report measures.
Surveys also will be administered to
teachers after the completion of the
program to examine ease and fidelity of
implementation, as well as impact in
knowledge and understanding of the
neurobiology of addiction. Surveys will
be administered to parents to obtain
parental reaction and opinion on the
materials and the degree to which
parents find the curriculum informative
and appropriate.
Frequency of Response: On occasion.
Affected Public: Middle school
students, teachers, and parents.
Type of Respondents: Students,
Teachers, and Parents. The reporting
burden is as follows: Estimated Number
of Respondents: 1,260.
Estimated Number of Responses per
Respondent: Students: 2, Parents and
Teachers: 1.
Average Burden Hours per Response:
Students: .5, Parents: .25 and Teachers:
.5.
Estimated Total Annual Burden
Hours Requested: 892.5. There are no
Capital Costs to report. There are no
Operating or Maintenance Costs to
report. The estimated annualized
burden is summarized below.
Frequency of
response
Average time
per response
Annual hour
burden
Students (K–grade 5) ......................................................................................
Students (grades 6–9) .....................................................................................
Parents (survey) (K–grade 5) ..........................................................................
Parents (survey) (grades 6–9) .........................................................................
Parents (postcard) (K–grade 5) .......................................................................
Parents (postcard) (grades 6–9) ......................................................................
Teachers (evaluation) ......................................................................................
Teachers (online survey) .................................................................................
375
375
25
25
200
200
30
30
2
2
1
1
1
1
1
1
.5
.5
.25
.25
.25
.25
.5
.5
375
375
6.25
6.25
50
50
15
15
Total ..........................................................................................................
1,260
........................
........................
892.50
VerDate Mar<15>2010
21:02 Jun 25, 2010
Jkt 220001
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
E:\FR\FM\28JNN1.SGM
28JNN1
36660
Federal Register / Vol. 75, No. 123 / Monday, June 28, 2010 / Notices
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) The accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
Ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact Dr. Cathrine Sasek,
Coordinator, Science Education
Program, Office of Science Policy and
Communications, National Institute on
Drug Abuse, 6001 Executive Blvd, Room
5237, Bethesda, MD 20892, or call nontoll-free number (301) 443–6071; fax
(301) 443–6277; or by e-mail to
csasek@nida.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60-days of the date of
this publication.
Dated: June 15, 2010.
Mary Affeldt,
Executive Officer, (OM Director, NIDA),
National Institutes of Health.
[FR Doc. 2010–15608 Filed 6–25–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0001]
Orthopaedic and Rehabilitation
Devices Panel of the Medical Devices
Advisory Committee; Notice of Meeting
jlentini on DSKJ8SOYB1PROD with NOTICES
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
VerDate Mar<15>2010
21:02 Jun 25, 2010
Jkt 220001
Name of Committee: Orthopaedic and
Rehabilitation Devices Panel of the
Medical Devices Advisory Committee.
General Function of the Committee:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on July 27, 2010, from 8 a.m. to 6
p.m.
Location: Holiday Inn, Ballroom, 2
Montgomery Village Ave., Gaithersburg,
MD.
Contact Person: Tracy Phillips, Food
and Drug Administration, Center for
Devices and Radiological Health, 10903
New Hampshire Ave., Bldg. 66, rm.
1611, Silver Spring, MD 20993–0002,
301–796–6150 or FDA Advisory
Committee Information Line, 1–800–
741–8138 (301–443–0572 in the
Washington, DC area), code
3014512521. Please call the Information
Line for up-to-date information on this
meeting. A notice in the Federal
Register about last minute modifications
that impact a previously announced
advisory committee meeting cannot
always be published quickly enough to
provide timely notice. Therefore, you
should always check the agency’s Web
site and call the appropriate advisory
committee hot line/phone line to learn
about possible modifications before
coming to the meeting.
Agenda: On July 27, 2010, the
committee will discuss, make
recommendations and vote on a
premarket approval application for the
AMPLIFY rhBMP-2 Matrix, sponsored
by Medtronic, Inc. The AMPLIFY
rhBMP-2 Matrix is used for
posterolateral fusion treatment of single
level lumbar (L2–S1) degenerative disc
disease.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before July 21, 2010. Oral
presentations from the public will be
scheduled between approximately 1 and
2 p.m., immediately following lunch.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Those desiring to make formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before July 13,
2010. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by July 14, 2010.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact AnnMarie
Williams, Conference Management
Staff, 301–796–5966, at least 7 days in
advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/Advisory
Committees/AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: June 18, 2010.
Thinh Nguyen,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2010–15350 Filed 6–23–10; 4:15 pm]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
E:\FR\FM\28JNN1.SGM
28JNN1
Agencies
[Federal Register Volume 75, Number 123 (Monday, June 28, 2010)]
[Notices]
[Pages 36659-36660]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-15608]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment Request; Brain Power! The NIDA
Junior Scientist Program and the Companion Program, Brain Power!
Challenge
SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for the opportunity for public
comment on proposed data collection projects, the National Institute on
Drug Abuse (NIDA), the National Institutes of Health (NIH) will publish
periodic summaries of proposed projects to be submitted to the Office
of Management and Budget (OMB) for review and approval.
Proposed Collection: Title: Brain Power! The NIDA Junior Scientist
Program, for grades K-5, and the companion program for Middle School,
the Brain Power! Challenge.
Type of Information Collection Request: NEW.
Need and Use of Information Collection: This is a request for
clearance to evaluate the effectiveness of the Brain Power! Program's
ability to:
Increase students' knowledge about the biology of the
brain and the neurobiology of drug addiction;
Increase positive attitudes toward science, careers in
science, and science as an enjoyable endeavor, and stimulating interest
in scientific careers; and
Promote more balanced perceptions and attitudes of
scientists as being of many races, ages, and genders
The secondary goal is to determine the influence or change of attitudes
toward and intentions about drug use. The findings will provide
valuable information concerning the goals of NIDA's Science Education
Program of increasing scientific literacy and stimulating interest in
scientific careers. In order to test the effectiveness of the
evaluation, information will be collected from students before and
after exposure to the curriculum with pre- and post-test self-report
measures. Surveys also will be administered to teachers after the
completion of the program to examine ease and fidelity of
implementation, as well as impact in knowledge and understanding of the
neurobiology of addiction. Surveys will be administered to parents to
obtain parental reaction and opinion on the materials and the degree to
which parents find the curriculum informative and appropriate.
Frequency of Response: On occasion.
Affected Public: Middle school students, teachers, and parents.
Type of Respondents: Students, Teachers, and Parents. The reporting
burden is as follows: Estimated Number of Respondents: 1,260.
Estimated Number of Responses per Respondent: Students: 2, Parents
and Teachers: 1.
Average Burden Hours per Response: Students: .5, Parents: .25 and
Teachers: .5.
Estimated Total Annual Burden Hours Requested: 892.5. There are no
Capital Costs to report. There are no Operating or Maintenance Costs to
report. The estimated annualized burden is summarized below.
----------------------------------------------------------------------------------------------------------------
Number of Frequency of Average time Annual hour
Types of respondents respondents response per response burden
----------------------------------------------------------------------------------------------------------------
Students (K-grade 5)............................ 375 2 .5 375
Students (grades 6-9)........................... 375 2 .5 375
Parents (survey) (K-grade 5).................... 25 1 .25 6.25
Parents (survey) (grades 6-9)................... 25 1 .25 6.25
Parents (postcard) (K-grade 5).................. 200 1 .25 50
Parents (postcard) (grades 6-9)................. 200 1 .25 50
Teachers (evaluation)........................... 30 1 .5 15
Teachers (online survey)........................ 30 1 .5 15
---------------------------------------------------------------
Total....................................... 1,260 .............. .............. 892.50
----------------------------------------------------------------------------------------------------------------
[[Page 36660]]
Request for Comments: Written comments and/or suggestions from the
public and affected agencies are invited on one or more of the
following points: (1) Whether the proposed collection of information is
necessary for the proper performance of the function of the agency,
including whether the information will have practical utility; (2) The
accuracy of the agency's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (3) Ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) Ways to minimize
the burden of the collection of information on those who are to
respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact Dr. Cathrine Sasek, Coordinator, Science Education
Program, Office of Science Policy and Communications, National
Institute on Drug Abuse, 6001 Executive Blvd, Room 5237, Bethesda, MD
20892, or call non-toll-free number (301) 443-6071; fax (301) 443-6277;
or by e-mail to csasek@nida.nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60-days
of the date of this publication.
Dated: June 15, 2010.
Mary Affeldt,
Executive Officer, (OM Director, NIDA), National Institutes of Health.
[FR Doc. 2010-15608 Filed 6-25-10; 8:45 am]
BILLING CODE 4140-01-P